Toggle Main Menu Toggle Search

Open Access padlockePrints

Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2

Lookup NU author(s): Dr Yvette DrewORCiD, Dr Evan Mulligan, Wan Vong, Huw ThomasORCiD, Suzanne Kyle, Dr Asima Mukhopadhyay, Professor Ruth PlummerORCiD, Professor Richard Edmondson, Professor Nicola CurtinORCiD

Downloads


Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Oxford University Press, 2011.

For re-use rights please refer to the publisher's terms and conditions.


Publication metadata

Author(s): Drew Y, Mulligan EA, Vong W, Thomas HD, Kahn S, Kyle S, Mukhopadhyay A, Los G, Hostomsky Z, Plummer ER, Edmondson RJ, Curtin NJ

Publication type: Article

Publication status: Published

Journal: Journal of the National Cancer Institute

Year: 2011

Volume: 103

Issue: 4

Pages: 334-346

Print publication date: 23/12/2010

Date deposited: 16/03/2011

ISSN (print): 0027-8874

ISSN (electronic): 1460-2105

Publisher: Oxford University Press

URL: http://dx.doi.org/10.1093/jnci/djq509

DOI: 10.1093/jnci/djq509

PubMed id: 21183737

Notes: Senior author: Nicola J. Curtin


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
140-N-1232663Pfizer, Inc
C9380/A7810Cancer Research UK

Share